VANGUARD GROUP INC - VIRACTA THERAPEUTICS INC ownership

VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 69 filers reported holding VIRACTA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of VIRACTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,193,828
-26.2%
1,147,9120.0%0.00%
Q2 2023$1,618,556
-11.3%
1,147,9120.0%0.00%
Q1 2023$1,825,180
+8.9%
1,147,9120.0%0.00%
Q4 2022$1,675,952
-64.8%
1,147,912
+3.0%
0.00%
Q3 2022$4,759,000
+35.2%
1,114,368
+22.8%
0.00%
Q2 2022$3,520,000
-10.8%
907,260
+9.5%
0.00%
Q1 2022$3,945,000
-25.7%
828,877
-43.0%
0.00%
Q4 2021$5,307,000
-54.2%
1,454,326
+0.7%
0.00%
Q3 2021$11,586,000
-28.7%
1,444,615
+0.7%
0.00%
Q2 2021$16,261,000
+745.2%
1,433,922
+589.2%
0.00%
Q1 2021$1,924,000208,0480.00%
Other shareholders
VIRACTA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Aisling Capital Management LP 288,571$421,3140.28%
BVF INC/IL 3,614,662$5,277,4070.22%
Samsara BioCapital, LLC 689,709$1,006,9750.22%
Rubric Capital Management LP 1,330,983$1,943,2350.08%
HAMILTON LANE ADVISORS LLC 35,791$520.02%
MAI Capital Management 426,916$623,2970.01%
Jasper Ridge Partners, L.P. 92,939$135,6910.01%
BOURGEON CAPITAL MANAGEMENT LLC 17,500$25,5500.01%
RP Management, LLC 3,700$5,4020.01%
Laurion Capital Management LP 698,000$1,019,0800.01%
View complete list of VIRACTA THERAPEUTICS INC shareholders